Basics Stoke Therapeutics, Inc. IPO Date: June 17, 2019 Sector: Healthcare Industry: Biotech Market Cap: $501.2M Activated in VL: True Average Daily Range Avg Daily Range: $0.66 | 3.35% Avg Daily Range (30 D): $0.31 | 3.36% Avg Daily Range (90 D): $0.34 | 3.83% Institutional Daily Volume Avg Daily Volume: .28M Avg Daily Volume (30 D): .61M Avg Daily Volume (90 D): .65M Trade Size Avg Trade Size (Sh.): 80 Avg Trade Size (Sh.) (30 D): 63 Avg Trade Size (Sh.) (90 D): 71 Institutional Trades Total Inst.Trades: 1,068 Avg Inst. Trade: $1.85M Avg Inst. Trade (30 D): $1.06M Avg Inst. Trade (90 D): $1.13M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.43M Avg Closing Trade (30 D): $.9M Avg Closing Trade (90 D): $.98M Avg Closing Volume: 88.41K         News Jun 28, 2024 @ 4:01 PM A Closer Look at 5 Analyst Recommendations For Sto... Source: Benzinga Insights May 6, 2024 @ 3:01 PM Analyst Expectations For Stoke Therapeutics's Futu... Source: Benzinga Insights May 6, 2024 @ 12:05 PM Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, T... Source: Zacks Equity Research Apr 29, 2024 @ 2:00 PM Earnings Preview: Axsome Therapeutics (AXSM) Q1 Ea... Source: Zacks Equity Research Apr 25, 2024 @ 2:01 PM Earnings Preview: Stoke Therapeutics, Inc. (STOK) ... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $.85 $1.95 $-.17 Diluted EPS $.8 $1.9 $-.17 Revenue $ 190.91M $ 158.57M $ 22.61M Gross Profit $ $ $ Net Income / Loss $ 50.27M $ 112.88M $ -10.48M Operating Income / Loss $ 38.24M $ 111.24M $ -13.65M Cost of Revenue $ $ $ Net Cash Flow $ 96.46M $ 146.83M $ -21.81M PE Ratio 12.29     Splits Jun 06, 2019:   10:99